282 related articles for article (PubMed ID: 28445495)
1. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.
Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P
PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold.
Hedges AR; Pypendop BH; Shilo-Benjamini Y; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2014 Jun; 37(3):252-9. PubMed ID: 24862514
[TBL] [Abstract][Full Text] [Related]
4. Postoperative analgesic effects of intravenous, intramuscular, subcutaneous or oral transmucosal buprenorphine administered to cats undergoing ovariohysterectomy.
Giordano T; Steagall PV; Ferreira TH; Minto BW; de Sá Lorena SE; Brondani J; Luna SP
Vet Anaesth Analg; 2010 Jul; 37(4):357-66. PubMed ID: 20636568
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses.
Love EJ; Pelligand L; Taylor PM; Murrell JC; Sear JW
Vet Anaesth Analg; 2015 Jan; 42(1):17-29. PubMed ID: 24735059
[TBL] [Abstract][Full Text] [Related]
7. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.
Kuhlman JJ; Lalani S; Magluilo J; Levine B; Darwin WD
J Anal Toxicol; 1996 Oct; 20(6):369-78. PubMed ID: 8889672
[TBL] [Abstract][Full Text] [Related]
8. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration.
Robertson SA; Lascelles BD; Taylor PM; Sear JW
J Vet Pharmacol Ther; 2005 Oct; 28(5):453-60. PubMed ID: 16207308
[TBL] [Abstract][Full Text] [Related]
9. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site.
Messenger KM; Davis JL; LaFevers DH; Barlow BM; Posner LP
Vet Anaesth Analg; 2011 Jul; 38(4):374-84. PubMed ID: 21501371
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial.
Steagall PV; Ruel HLM; Yasuda T; Monteiro BP; Watanabe R; Evangelista MC; Beaudry F
BMC Vet Res; 2020 May; 16(1):154. PubMed ID: 32448336
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations and behavioral, antinociceptive, and physiologic effects of methadone after intravenous and oral transmucosal administration in cats.
Ferreira TH; Rezende ML; Mama KR; Hudachek SF; Aguiar AJ
Am J Vet Res; 2011 Jun; 72(6):764-71. PubMed ID: 21627522
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of intravenous administration of hydromorphone hydrochloride alone or followed by buprenorphine hydrochloride or butorphanol tartrate to healthy conscious cats.
Simon BT; Steagall PV; Monteiro BP; Troncy E; Lizarraga I
Am J Vet Res; 2016 Mar; 77(3):245-51. PubMed ID: 26919594
[TBL] [Abstract][Full Text] [Related]
13. Thermal antinociception following oral administration of tapentadol in conscious cats.
Doodnaught GM; Evangelista MC; Steagall PVM
Vet Anaesth Analg; 2017 Mar; 44(2):364-369. PubMed ID: 28242230
[TBL] [Abstract][Full Text] [Related]
14. The thermal antinociceptive effects of a high-concentration formulation of buprenorphine alone or followed by hydromorphone in conscious cats.
Moreno KL; Scallan EM; Monteiro BP; Steagall PV; Simon BT
Vet Anaesth Analg; 2021 Jul; 48(4):570-576. PubMed ID: 33926823
[TBL] [Abstract][Full Text] [Related]
15. Preliminary investigation of the thermal antinociceptive effects of codeine in cats.
Steagall PV; Monteiro BP; Lavoie AM; Troncy E
J Feline Med Surg; 2015 Dec; 17(12):1061-4. PubMed ID: 25572305
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a Sustained Release Formulation of Buprenorphine After Intramuscular and Subcutaneous Administration to American Kestrels ( Falco sparverius ).
Guzman DS; Knych HK; Olsen GH; Paul-Murphy JR
J Avian Med Surg; 2017 Jun; 31(2):102-107. PubMed ID: 28644085
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits.
Askar R; Fredriksson E; Manell E; Hedeland M; Bondesson U; Bate S; Olsén L; Hedenqvist P
BMC Vet Res; 2020 Nov; 16(1):436. PubMed ID: 33176781
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius).
Gustavsen KA; Guzman DS; Knych HK; Petritz OA; Olsen GH; Paul-Murphy JR
Am J Vet Res; 2014 Aug; 75(8):711-5. PubMed ID: 25061701
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic comparison of two buprenorphine formulations after buccal administration in healthy male cats.
Gulledge BM; Messenger KM; Cornell KK; Lindell H; Schmiedt CW
J Feline Med Surg; 2018 Apr; 20(4):312-318. PubMed ID: 28569590
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.
Abbo LA; Ko JC; Maxwell LK; Galinsky RE; Moody DE; Johnson BM; Fang WB
Vet Ther; 2008; 9(2):83-93. PubMed ID: 18597246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
